JP Bilezikian

507 total citations
17 papers, 133 citations indexed

About

JP Bilezikian is a scholar working on Nephrology, Oncology and Surgery. According to data from OpenAlex, JP Bilezikian has authored 17 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in JP Bilezikian's work include Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (5 papers) and Bone health and osteoporosis research (3 papers). JP Bilezikian is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Bone health and treatments (5 papers) and Bone health and osteoporosis research (3 papers). JP Bilezikian collaborates with scholars based in United States, Italy and Canada. JP Bilezikian's co-authors include A Morishima, Jimmy D. Bell, Ketcham As, D. W. Powell, Wells Sa, JL Doppman, Aldo Pinchera, Stefania Bonadonna, Elena Ambrogini and Ernesto Canalis and has published in prestigious journals such as New England Journal of Medicine, Journal of Bone and Mineral Research and Bone.

In The Last Decade

JP Bilezikian

16 papers receiving 124 citations

Peers

JP Bilezikian
Comparison fields: 5 of 38
  • Oncology 70
  • Orthopedics and Sports Medicine 53
  • Nephrology 47
  • Molecular Biology 42
  • Genetics 26
Graham Ellis United States
Neveen A. T. Hamdy Netherlands
E Shane United States
Pablo A. Ureña Torres France
Julia Krupinova Russia
Tanja Gmeiner Stopar Slovenia
Jung‐Fu Chen Taiwan
Agnieszka Rusińska Poland
Giulia Leanza Italy
R. Carpinteri Italy
Graham Ellis United States View profile →
Citations per field, relative to JP Bilezikian
JP Bilezikian · 1×
Citations per year, relative to JP Bilezikian
JP Bilezikian · 1×

Countries citing papers authored by JP Bilezikian

Since Specialization
Citations

This map shows the geographic impact of JP Bilezikian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JP Bilezikian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JP Bilezikian more than expected).

Fields of papers citing papers by JP Bilezikian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JP Bilezikian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JP Bilezikian. The network helps show where JP Bilezikian may publish in the future.

Co-authorship network of co-authors of JP Bilezikian

This figure shows the co-authorship network connecting the top 25 collaborators of JP Bilezikian. A scholar is included among the top collaborators of JP Bilezikian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JP Bilezikian. JP Bilezikian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Title Journal Authors Indexed citations
1 Bone-density testing interval and transition to osteoporosis. New England Journal of Medicine JP Bilezikian et al. 2
2 Gains in lumbar spine BMD in highly compliant patients treated with PTH (1–84) Bone D Black, JP Bilezikian et al. 1
3 Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment Journal of Endocrinological Investigation Filomena Cetani, Elena Pardi et al. 17
4 Prevention and treatment of glucocorticoid-induced osteoporosis. PubMed Mauro Doga, Gherardo Mazziotti et al. 14
5 High resolution peripheral quantitative CT (HRpQCT) of the radius reflects iliac crest biopsy measures of microstructure and mechanical competence Journal of Bone and Mineral Research Avi J. Cohen, D. W. Dempster et al. 0
6 Parathyroid hormone as an anabolic therapy for women and men. PubMed JP Bilezikian et al. 30
7 A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism JP Bilezikian et al. 6
8 Shinall Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. JP Bilezikian et al. 8
9 Influence of intermittent PTH treatment on mineral distribution in the human ilium: A paired biopsy study before and after treatment. Journal of Bone and Mineral Research Paul Roschger, BM Grabner et al. 5
10 Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency The Endocrinologist JP Bilezikian, A Morishima et al. 14
11 Current and future nonhormonal approaches to the treatment of osteoporosis. PubMed JP Bilezikian 9
12 Relationship between bone mass by densitometry and by histomorphometry in primary hyperparathyroidism and in osteoporosis Bone and Mineral May Parisien, Felicia Cosman et al. 1
13 Structural variables in postmenopausal women: Comparison among normal women and patients with osteoporosis or primary hyperparathyroidism Bone May Parisien, Jeri W. Nieves et al. 2
14 Osteoporosis and fractures after cardiac transplantation Bone and Mineral Elizabeth Shane, Shonni J. Silverberg et al. 1
15 Long-term maintenance of responsive human parathyroid tissue in organ culture. PubMed JP Bilezikian, Hardy Ma et al. 2
16 Hypercalcemia: the changing clinical profile. PubMed JP Bilezikian 2
17 Repeated neck exploration in primary hyperparathyroidism: localization of abnormal glands by selective thyroid arteriography, selective venous sampling, and radioimmunoassay. PubMed Wells Sa, JL Doppman et al. 19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026